Correction

Published on 03 May 2023

Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth

in Pharmacology of Anti-Cancer Drugs

Uttara Saran
Balaji Chandrasekaran
Ashish Tyagi
Vaibhav Shukla
Amandeep Singh
Arun K. Sharma
Chendil Damodaran

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1207589

932 views

Original Research

Published on 02 May 2023

A novel risk model of three SUMOylation genes based on RNA expression for potential prognosis and treatment sensitivity prediction in kidney cancer

in Pharmacology of Anti-Cancer Drugs

Song-Chao Li
Li-Jie Yan
Xu-Liang Wei
Zhan-Kui Jia
Jin-Jian Yang
Xiang-Hui Ning

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1038457

2,168 views

Systematic Review

Published on 02 May 2023

Anti-cancer activity of guggulsterone by modulating apoptotic markers: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Meenakshi Gupta
Deepti Singh
Shruti Rastogi
Hifzur R. Siddique
Noura Al-Dayan
Ajaz Ahmad
Mohammad Sikander
Maryam Sarwat

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1155163

5,649 views
6 citations

Original Research

Published on 28 Apr 2023

Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003

in Pharmacology of Anti-Cancer Drugs

Yuhan Liu
Ruixiao Wang
Ru Huang
Beata Rutz
Anna Ciotkowska
Alexander Tamalunas
Sheng Hu
Moritz Trieb
Raphaela Waidelich
Frank Strittmatter

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1105427

3,327 views
4 citations

Review

Published on 28 Apr 2023

Management and prediction of immune-related adverse events for PD1/PDL-1 immunotherapy in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Liting Sun
Cong Meng
Xiao Zhang
Jiale Gao
Pengyu Wei
Jie Zhang
Zhongtao Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1167670

3,740 views
2 citations

Original Research

Published on 27 Apr 2023

The molecular mechanism for inhibiting the growth of nasopharyngeal carcinoma cells using polymethoxyflavonoids purified from pericarp of Citrus reticulata ‘Chachi’ via HSCCC

in Pharmacology of Anti-Cancer Drugs

Wanling Yang
Yiyao Liang
Yujie Liu
Baizhong Chen
Kanghui Wang
Xiaojing Chen
Zhiqian Yu
Depo Yang
Yi Cai
Guodong Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1096001

1,852 views
4 citations

Review

Published on 27 Apr 2023

Antitumor effects and potential mechanisms of aconitine based on preclinical studies: an updated systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Gelin Xiang
Nan Xing
Shaohui Wang
Yi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172939

3,554 views
5 citations

Original Research

Published on 26 Apr 2023

Predictive model of chemotherapy-related toxicity in elderly Chinese cancer patients

in Pharmacology of Anti-Cancer Drugs

Yuwei Hua
Yuling Zou
Mei Guan
Hsiang-Yu Yuan
Yanping Zhou
Fengshuo Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1158421

2,239 views
2 citations

Review

Published on 26 Apr 2023

Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors

in Pharmacology of Anti-Cancer Drugs

Qiuyu Wu
Yuanhang Xia
Xiaohe Xiong
Xinxing Duan
Xiaoxiao Pang
Fugui Zhang
Song Tang
Junlei Su
Shuqiong Wen
Li Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1169608

3,049 views
4 citations

Original Research

Published on 26 Apr 2023

Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner

in Pharmacology of Anti-Cancer Drugs

Hongye Zou
Yatian Yang
Hong-Wu Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1146741

2,939 views
5 citations

Original Research

Published on 25 Apr 2023

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Jianxiang Zhang
Liwen Liu
Zenghan Wang
Mingyang Hou
Zihui Dong
Jia Yu
Ranran Sun
Guangying Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172908

3,117 views
5 citations

Systematic Review

Published on 25 Apr 2023

Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Qiyu Tang
Dawei Wu
Huiyao Huang
Hong Fang
Ying Wu
Funan Liu
Ning Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1093194

2,010 views
2 citations

Original Research

Published on 24 Apr 2023

Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts

in Pharmacology of Anti-Cancer Drugs

Chunyu Zhang
Jiatong Xiao
Tong Yuan
Yunbo He
Dingshan Deng
Zicheng Xiao
Jinbo Chen
Xiongbing Zu
Peihua Liu
Zhi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1163115

2,686 views
3 citations

Original Research

Published on 24 Apr 2023

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB

in Pharmacology of Anti-Cancer Drugs

Shike Lou
Zhujun Cao
Wanqing Chi
Xiaoyin Wang
Mingyang Feng
Lanyi Lin
Yezhou Ding
Kehui Liu
Lihong Qu
Gangde Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164309

2,500 views
7 citations

Review

Published on 24 Apr 2023

Emerging role of ferroptosis-related circular RNA in tumor metastasis

in Pharmacology of Anti-Cancer Drugs

Yifei Meng
Jingdong Cao
Yidan Li
Saili Duan
Zongjiang Zhou
Jinghe Li
Diabate Ousmane
Chunlin Ou
Junpu Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1168458

2,445 views
4 citations

Original Research

Published on 24 Apr 2023

Global publication trends and research trends of necroptosis application in tumor: A bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Yun-Yun Wu
Chang-chun Li
Xiao Lin
Feng Xu
Su-Kang Shan
Bei Guo
Fu-Xing-Zi Li
Ming-Hui Zheng
Qiu-Shuang Xu
Li-Min Lei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1112484

3,556 views
1 citation

Navigation group

Articles

Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth

A novel risk model of three SUMOylation genes based on RNA expression for potential prognosis and treatment sensitivity prediction in kidney cancer

Anti-cancer activity of guggulsterone by modulating apoptotic markers: a systematic review and meta-analysis

Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003

Management and prediction of immune-related adverse events for PD1/PDL-1 immunotherapy in colorectal cancer

The molecular mechanism for inhibiting the growth of nasopharyngeal carcinoma cells using polymethoxyflavonoids purified from pericarp of Citrus reticulata ‘Chachi’ via HSCCC

Antitumor effects and potential mechanisms of aconitine based on preclinical studies: an updated systematic review and meta-analysis

Predictive model of chemotherapy-related toxicity in elderly Chinese cancer patients

Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors

Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma

Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis

Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB

Emerging role of ferroptosis-related circular RNA in tumor metastasis

Global publication trends and research trends of necroptosis application in tumor: A bibliometric analysis